In recognition of SMA Awareness Month, NeurologyLive® spoke with neuromuscular experts about how multidisciplinary care is ...
The FDA was busy early this month, during the week of August 23, 2026, making a number of decisions on potential new ...
NeurologyLive Brain Games is a weekly, Sunday-morning quiz series featuring three questions authored by clinicians and ...
In honor of SMA Awareness Month, held annually throughout August, get caught up on the latest news in spinal muscular atrophy ...
The FDA has been busy this week, making multiple decisions over just a few days. The administration kicked off the week by ...
The vice president of Neuroscience and Vaccines at Takeda discusses the clinical significance of oveporexton's FDA approval ...
Updates to the MRI Protocol and Clinical Guidelines for MS: CMSC Working Group | Peer Exchange | NeurologyLive is your direct connection to the latest neurology news and interviews with expert ...
In recognition of SMA Awareness Month, held annually throughout August, NeurologyLive® reviews the investigational agents ...
Cellenkos’ investigational allogeneic, cord blood-derived T-regulatory cell therapy is being evaluated in a phase 1/1b study in ALS, with early findings showing reductions in plasma neurofilament ...
FDA has cleared C2N Diagnostics' PrecivityAD2 blood test for adults 40 years and older with cognitive symptoms, offering fast amyloid and tau insight to guide diagnosis and trials in Alzheimer disease ...
Dustin Gable, MD, PhD, a pediatric neuromuscular neurologist at Johns Hopkins Medicine, discussed why bulbar dysfunction ...
The American Heart Association (AHA) and American Stroke Association (ASA) have published the "2026 Guideline for Adult ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results